Gender-specific effects of estrogen receptor α gene haplotype on high-density lipoprotein cholesterol response to atorvastatin: interaction with apolipoprotein AI gene polymorphism
- 28 February 2005
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 178 (2) , 331-338
- https://doi.org/10.1016/j.atherosclerosis.2004.08.034
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Association of serum low-density lipoprotein metabolism with oestrogen receptor gene polymorphisms in healthy childrenActa Paediatrica, 2007
- Apo A-I promoter polymorphism influences basal HDL-cholesterol and its response to pravastatin therapyAtherosclerosis, 2003
- Simvastatin, an HMG-CoA reductase inhibitor, induces the synthesis and secretion of apolipoprotein AI in HepG2 cells and primary hamster hepatocytesAtherosclerosis, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Association of Estrogen Receptor-α Gene Polymorphisms With Coronary Artery Disease in Patients With Familial HypercholesterolemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Effects of apolipoprotein A‐I genetic variations on plasma apolipoprotein, serum lipoprotein and glucose levelsClinical Genetics, 2002
- Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-IJournal of Clinical Investigation, 2001
- Candidate-Gene Studies of the Atherogenic Lipoprotein Phenotype: A Sib-Pair Linkage Analysis of DZ Women TwinsAmerican Journal of Human Genetics, 1998
- Association of bone mineral density with polymorphism of the estrogen receptor geneJournal of Bone and Mineral Research, 1996
- A Major Locus Influencing Plasma High-Density Lipoprotein Cholesterol Levels in the San Antonio Family Heart StudyArteriosclerosis, Thrombosis, and Vascular Biology, 1995